Related references
Note: Only part of the references are listed.MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy
Zhenyou Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia
Julie Rousseau et al.
BLOOD (2011)
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
G. Vignir Helgason et al.
BLOOD (2011)
HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells
Mingyi Zhao et al.
BMB REPORTS (2011)
The Beclin 1 network regulates autophagy and apoptosis
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2011)
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Ravi K. Amaravadi et al.
CLINICAL CANCER RESEARCH (2011)
microRNA-101 is a potent inhibitor of autophagy
Lisa B. Frankel et al.
EMBO JOURNAL (2011)
The dynamic nature of autophagy in cancer
Alec C. Kimmelman
GENES & DEVELOPMENT (2011)
Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells
Geylani Can et al.
HEMATOLOGY (2011)
Cytoprotective effect of imatinib mesylate in non-BCR-ABL-expressing cells along with autophagosome formation
Tadashi Ohtomo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Autophagy regulation by p53
Maria Chiara Maiuri et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Autophagy and the Integrated Stress Response
Guido Kroemer et al.
MOLECULAR CELL (2010)
Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
F. Yu et al.
ONCOGENE (2010)
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
Marcus Jaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
miR-30 Regulates Mitochondrial Fission through Targeting p53 and the Dynamin-Related Protein-1 Pathway
Jincheng Li et al.
PLOS GENETICS (2010)
Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells
Hua Zhu et al.
AUTOPHAGY (2009)
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes
Mika Inomata et al.
BLOOD (2009)
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
Cristian Bellodi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABLI-mutations
Edurne San Jose-Eneriz et al.
MOLECULAR CANCER (2009)
The role of microRNA in human leukemia: a review
S. Yendamuri et al.
LEUKEMIA (2009)
Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells
P. Gamas et al.
LEUKEMIA (2009)
MONITORING AUTOPHAGY BY ELECTRON MICROSCOPY IN MAMMALIAN CELLS
Paivi Yla-Anttila et al.
METHODS IN ENZYMOLOGY: AUTOPHAGY IN MAMMALIAN SYSTEMS, VOL 452, PT B (2009)
Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease
Peter Valent
BRITISH JOURNAL OF HAEMATOLOGY (2008)
TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
A. Petitjean et al.
ONCOGENE (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Lithium induces autophagy by inhibiting inositol monophosphatase
S Sarkar et al.
JOURNAL OF CELL BIOLOGY (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
R Bhatia et al.
BLOOD (2003)
Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene
S Durland-Busbice et al.
LEUKEMIA (2002)